Showing results (181-190 of 277) with videos related to
Sort By:
Pageof 28
Current Medical Research and Opinion|October 8, 2024
Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trialJudith Trotman, Pier Luigi Zinzani, Yuqin Song, et al.Frontiers in Immunology|April 21, 2023
Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II studyYanfei Liu, Yuqin Song, Shubo Zuo, et al.Clinical Pharmacology in Drug Development|July 3, 2025
A Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT-101, an RNAi Therapeutic Targeting HBV InfectionJianxiong Zhang, Jiangshuo Li, Le Wu, et al.Cancer Letters|March 7, 2025
Interleukin-2-inducible T-cell kinase inhibition to block NF-κB signaling exerts anti-tumor effects and enhances chemotherapy in NK/T-cell lymphomaJiaowu Cao, Dingyao Hu, Hui Yu, et al.The Lancet. Haematology|May 30, 2025
Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignanciesPaul J Bröckelmann, Edward R Scheffer Cliff, Gloria Iacoboni, et al.Microbiology Spectrum|January 19, 2022
ECF Sigma Factor HxuI Is Critical for <i>In Vivo</i> Fitness of <i>Pseudomonas aeruginosa</i> during InfectionZeqiong Cai, Fan Yang, Xiaolong Shao, et al.Medcomm|June 18, 2025
Genetic Subtype-Based International Prognostic Index Prognostic Model in Diffuse Large B-Cell LymphomaLan Mi, Jili Deng, Jiayue Qin, et al.Zhonghua Yi Xue Za Zhi|December 31, 2014
[Clinical value of flow cytometry in assessing bone marrow involvement of non-Hodgkin's lymphoma]Weiwei Song, Yan Xie, Lijuan Deng, et al.Cancer Medicine|December 31, 2020
Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in ChinaZhitao Ying, Haiyan Yang, Ye Guo, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Prognostic value of pre- and post-transplantation <sup>18</sup>F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantationZhitao Ying, Lan Mi, Xuejuan Wang, et al.Pageof 28